http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7504516-B2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9b4f16ad70ddfeb0b838c113aaae408a
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D403-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D257-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D403-10
filingDate 2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2009-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5135fad9fd7caaa06d42f33c1b827e7d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1e281536d0b4fc5374dfb2d4e10ab0d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ae913d1fe3e4f1d66f0e8401fe017726
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e80107e622dc5b02541d1931f76e81b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_86f298c66882cff926861cd940ead4a4
publicationDate 2009-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber US-7504516-B2
titleOfInvention Crystalline forms of candesartan cilexetil
abstract The present invention relates to two novel crystalline forms and a novel 1,4-dioxane solvate of candesartan cilexetil, to processes for their preparation and to pharmaceutical compositions containing them.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8989412-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2012057730-A1
priorityDate 2003-03-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4602017-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004102523-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004083191-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0881212-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02068398-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5196444-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0668272-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2540
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419581751
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414855894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396025
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID31275
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127955086
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6404
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11787332
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128111715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419520719
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226425988
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2541
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227953358
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID142305086

Total number of triples: 43.